Figure 2 - Example highlighting the distinct mechanisms of antiviral actions by pharmacological inhibitors of cellular cyclin-dependent kinases (CDKs) compared to conventional antiviral drugs.


From the following article

Systems biology and the host response to viral infection

Seng-Lai Tan, Gopinath Ganji, Bryan Paeper, Sean Proll & Michael G Katze

Nature Biotechnology 25, 1383 - 1389 (2007)

doi:10.1038/nbt1207-1383

BACK TO ARTICLE
Unfortunately we are unable to provide accessible alternative text for this. If you require assistance to access this image, or to obtain a text description, please contact npg@nature.com

The illustration depicts the viral functions that are directly repressed by CDK inhibitors or by two typical antiviral drugs, acyclovir and foscarnet. Because CDKs are required for transcription of HSV immediate-early (IE), early (E) and perhaps late (L) genes, and for viral DNA replication, CDK inhibitors can target several stages of the viral replication cycle as opposed to blocking a specific viral target(s), such as the viral thymidine kinase (TK) or DNA polymerase (DNA pol). Thus, a single drug targeting a single cellular protein that is required for several viral functions is akin to combination antiviral therapy, in which each drug targets a different viral enzymes. Hel./prim, helicase-primase. Reproduced with permission from Luis Schang.

BACK TO ARTICLE